PRESCIENT THERAPEUTICS LIMITED - Announcements

Market Cap $31.40M Add to my watchlist

Healthcare Biotechnology

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Announcements

Filter Results

All Price Sensitive Only

PTX	Application for quotation of securities - PTX		07/12/21	25KB	Share
PTX	Application for quotation of securities - PTX		30/11/21	30.37KB	Share
PTX	Section 708A Cleansing Statement		30/11/21	238.85KB	Share
PTX	PTX adds International CAR-T & Bioengineering Experts to SAB		19/11/21	312.65KB	Share
PTX	Results of Annual General Meeting		12/11/21	270.99KB	Share
PTX	AGM Presentation		12/11/21	3.28MB	Share
PTX	Chair's Address to the 2021 Annual General Meeting		12/11/21	274.9KB	Share
PTX	Notification regarding unquoted securities - PTX		05/11/21	27.54KB	Share
PTX	Application for quotation of securities - PTX		04/11/21	24.97KB	Share
PTX	September 2021 Quarterly Activities and Appendix 4C	PRICE SENSITIVE	28/10/21	417.33KB	Share
PTX	Investor Presentation - October 2021	PRICE SENSITIVE	13/10/21	2.75MB	Share
PTX	PTX data demonstrates key OmniCAR features in next gen CAR-T	PRICE SENSITIVE	13/10/21	631.85KB	Share
PTX	Application for quotation of securities - PTX		08/10/21	24.97KB	Share
PTX	Notice of Annual General Meeting/Proxy Form		06/10/21	560.14KB	Share
PTX	Application for quotation of securities - PTX		14/09/21	27.77KB	Share
PTX	Section 708A Cleansing Statement		14/09/21	243.03KB	Share
PTX	Notification of cessation of securities - PTX		01/09/21	21.83KB	Share
PTX	Application for quotation of securities - PTX		01/09/21	25.2KB	Share
PTX	Section 708A Cleansing Statement		01/09/21	241.61KB	Share
PTX	Application for quotation of securities - PTX		31/08/21	24.97KB	Share
PTX	Appendix 4G and Corporate Governance Statement		30/08/21	667.05KB	Share
PTX	Appendix 4E and 2021 Annual Report	PRICE SENSITIVE	30/08/21	1.34MB	Share
PTX	Global brain cancer expert joins PTX advisory board		19/08/21	290.53KB	Share
PTX	Investor Presentation		04/08/21	1.79MB	Share
PTX	June 2021 Quarterly Activities and Appendix 4C	PRICE SENSITIVE	30/07/21	393.29KB	Share
PTX	PTX-100 trial advances following successful Phase 1b	PRICE SENSITIVE	27/07/21	384.64KB	Share
PTX	Application for quotation of securities - PTX		26/07/21	24.96KB	Share
PTX	Application for quotation of securities - PTX		20/07/21	24.96KB	Share
PTX	Notification regarding unquoted securities - PTX		13/07/21	28.87KB	Share
PTX	Application for quotation of securities - PTX		12/07/21	24.89KB	Share
PTX	Notification regarding unquoted securities - PTX		08/07/21	29.02KB	Share
PTX	Notification regarding unquoted securities - PTX		08/07/21	28.87KB	Share
PTX	PTX successful immunogenicity testing of OmniCAR	PRICE SENSITIVE	05/07/21	364.06KB	Share
PTX	Application for quotation of securities - PTX		30/06/21	24.89KB	Share
PTX	PTX Completes CAR-T Manufacturing Milestone for OmniCAR	PRICE SENSITIVE	24/06/21	393.66KB	Share
PTX	Response to ASX Price Query	PRICE SENSITIVE	03/06/21	404.55KB	Share
PTX	Capital Structure Update - Expiry of Unlisted Options		17/05/21	300.22KB	Share
PTX	PTX signs CAR-T agreement with Peter MacCallum	PRICE SENSITIVE	10/05/21	306.4KB	Share
PTX	March 2021 Quarterly Update and Appendix 4C	PRICE SENSITIVE	29/04/21	215.54KB	Share
PTX	PTX-200 AML Trial Progresses to Higher Dose	PRICE SENSITIVE	23/04/21	344.35KB	Share
PTX	Capital Structure Update - Expiry of Unlisted Options		20/04/21	295.84KB	Share
PTX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/02/21	798.25KB	Share
PTX	December 2020 Quarterly Update and Appendix 4C	PRICE SENSITIVE	28/01/21	314.36KB	Share
PTX	PTX announces 3 next-gen CAR-T programs with OmniCAR	PRICE SENSITIVE	18/01/21	1.91MB	Share
PTX	Appendix 3G		21/12/20	646.1KB	Share
PTX	Change of Director's Interest Notices x4		17/12/20	478.43KB	Share
PTX	Leading International Blood Cancer Specialist Joins PTX SAB		17/12/20	300.48KB	Share
PTX	Appendix 3G		10/12/20	750.16KB	Share
PTX	Issue of Unlisted Options		10/12/20	478.59KB	Share
PTX	PTX Extends COVID-19 Testing Program with Doherty Institute		09/12/20	374.67KB	Share
PTX	Amendment of Results of Annual General Meeting		25/11/20	508.67KB	Share
PTX	Constitution		24/11/20	784.62KB	Share
PTX	Results of Annual General Meeting		24/11/20	333.58KB	Share
PTX	AGM Presentation	PRICE SENSITIVE	24/11/20	2.08MB	Share
PTX	Ceasing to be a substantial holder from AEF		20/11/20	248.19KB	Share
PTX	Prescient Receives $1.03m R&D Tax Rebate	PRICE SENSITIVE	11/11/20	298.41KB	Share
PTX	PTX receives New Patent on Companion Diagnostic for PTX-100		26/10/20	319.15KB	Share
PTX	Expiry of Unlisted Options		20/10/20	131.27KB	Share
PTX	September 2020 Quarterly Update and Appendix 4C	PRICE SENSITIVE	20/10/20	183.81KB	Share
PTX	Notice of Annual General Meeting/Proxy Form		15/10/20	878.45KB	Share
PTX	Response to ASX Query	PRICE SENSITIVE	16/09/20	335.57KB	Share
PTX	Ceasing to be a substantial holder		03/09/20	57.63KB	Share
PTX	Change in Substantial Holding from AEF		02/09/20	194.62KB	Share
PTX	Section 708A Cleansing Notice and Appendix 2A		31/08/20	288.46KB	Share
PTX	Change of Director's Interest Notice		31/08/20	79.78KB	Share
PTX	Becoming a Substantial Holder from AEF		27/08/20	219.82KB	Share
PTX	Ceasing to be a substantial holder from AEF		26/08/20	250.89KB	Share
PTX	Proposed issue of Securities - PTX		26/08/20	25.05KB	Share
PTX	PTX Raises $7 million via Strongly Supported Placement	PRICE SENSITIVE	26/08/20	147KB	Share
PTX	Appendix 4G and Corporate Governance Statement		25/08/20	434.18KB	Share
PTX	Appendix 4E and 2020 Annual Report	PRICE SENSITIVE	25/08/20	1.06MB	Share
PTX	Appendix 2A		24/08/20	214.69KB	Share
PTX	Completion of $6.5 million Share Purchase Plan		21/08/20	131.31KB	Share
PTX	Update - Proposed issue of Securities - PTX		18/08/20	204.46KB	Share
PTX	Successful SPP Closed Early	PRICE SENSITIVE	18/08/20	146.86KB	Share
PTX	Update - Proposed issue of Securities - PTX		14/08/20	204.33KB	Share
PTX	Extension of Share Purchase Plan	PRICE SENSITIVE	14/08/20	137.09KB	Share
PTX	PTX Announces Cell Therapy Collaboration with Peter Mac	PRICE SENSITIVE	14/08/20	145.5KB	Share
PTX	PTX-100 progresses to next cohort in basket clinical study	PRICE SENSITIVE	12/08/20	175.99KB	Share
PTX	Globally Renowned CAR-T expert joins PTX Advisory Board		07/08/20	135.81KB	Share
PTX	Prescient Therapeutics Investor Briefing		04/08/20	179.24KB	Share
PTX	PTX-200 AML Trial Progresses to Next Dose Level	PRICE SENSITIVE	03/08/20	133.1KB	Share
PTX	Share Purchase Plan Booklet		27/07/20	441.34KB	Share
PTX	Section 708A Cleansing Notice		27/07/20	81.05KB	Share
PTX	Proposed issue of Securities - PTX		27/07/20	29.43KB	Share
PTX	Prescient Therapeutics Launches Share Purchase Plan	PRICE SENSITIVE	27/07/20	137.29KB	Share
PTX	Change in substantial Holding from AEF		24/07/20	103.34KB	Share
PTX	Trading Halt	PRICE SENSITIVE	24/07/20	186.08KB	Share
PTX	June 2020 Quarterly Update and Appendix 4C	PRICE SENSITIVE	22/07/20	227.48KB	Share
PTX	Securities Trading Policy		21/07/20	195.17KB	Share
PTX	2 PTX Assets Chosen in Doherty Institute COVID-19 Program	PRICE SENSITIVE	21/07/20	143.57KB	Share
PTX	Trading Halt	PRICE SENSITIVE	20/07/20	219.28KB	Share
PTX	Trading Pause	PRICE SENSITIVE	20/07/20	115.51KB	Share
PTX	Change of Auditor		10/07/20	122.12KB	Share
PTX	PTX Receives Two US Patents Covering PTX-200 - Amended		17/06/20	150.23KB	Share
PTX	PTX Receives Two US Patents Covering PTX-200		17/06/20	142.73KB	Share
PTX	Initial Director's Interest Notice		01/06/20	88.62KB	Share
PTX	Appendix 3G		01/06/20	136.71KB	Share
PTX	Former Juno Executive Joins Prescient Board		01/06/20	141.3KB	Share
PTX	PTX universal CAR-T platform presentation		26/05/20	2.19MB	Share

PTX Application for quotation of securities - PTX
07/12/21		25KB	Share
PTX Application for quotation of securities - PTX
30/11/21		30.37KB	Share
PTX Section 708A Cleansing Statement
30/11/21		238.85KB	Share
PTX PTX adds International CAR-T & Bioengineering Experts to SAB
19/11/21		312.65KB	Share
PTX Results of Annual General Meeting
12/11/21		270.99KB	Share
PTX AGM Presentation
12/11/21		3.28MB	Share
PTX Chair's Address to the 2021 Annual General Meeting
12/11/21		274.9KB	Share
PTX Notification regarding unquoted securities - PTX
05/11/21		27.54KB	Share
PTX Application for quotation of securities - PTX
04/11/21		24.97KB	Share
PTX September 2021 Quarterly Activities and Appendix 4C
28/10/21	PRICE SENSITIVE	417.33KB	Share
PTX Investor Presentation - October 2021
13/10/21	PRICE SENSITIVE	2.75MB	Share
PTX PTX data demonstrates key OmniCAR features in next gen CAR-T
13/10/21	PRICE SENSITIVE	631.85KB	Share
PTX Application for quotation of securities - PTX
08/10/21		24.97KB	Share
PTX Notice of Annual General Meeting/Proxy Form
06/10/21		560.14KB	Share
PTX Application for quotation of securities - PTX
14/09/21		27.77KB	Share
PTX Section 708A Cleansing Statement
14/09/21		243.03KB	Share
PTX Notification of cessation of securities - PTX
01/09/21		21.83KB	Share
PTX Application for quotation of securities - PTX
01/09/21		25.2KB	Share
PTX Section 708A Cleansing Statement
01/09/21		241.61KB	Share
PTX Application for quotation of securities - PTX
31/08/21		24.97KB	Share
PTX Appendix 4G and Corporate Governance Statement
30/08/21		667.05KB	Share
PTX Appendix 4E and 2021 Annual Report
30/08/21	PRICE SENSITIVE	1.34MB	Share
PTX Global brain cancer expert joins PTX advisory board
19/08/21		290.53KB	Share
PTX Investor Presentation
04/08/21		1.79MB	Share
PTX June 2021 Quarterly Activities and Appendix 4C
30/07/21	PRICE SENSITIVE	393.29KB	Share
PTX PTX-100 trial advances following successful Phase 1b
27/07/21	PRICE SENSITIVE	384.64KB	Share
PTX Application for quotation of securities - PTX
26/07/21		24.96KB	Share
PTX Application for quotation of securities - PTX
20/07/21		24.96KB	Share
PTX Notification regarding unquoted securities - PTX
13/07/21		28.87KB	Share
PTX Application for quotation of securities - PTX
12/07/21		24.89KB	Share
PTX Notification regarding unquoted securities - PTX
08/07/21		29.02KB	Share
PTX Notification regarding unquoted securities - PTX
08/07/21		28.87KB	Share
PTX PTX successful immunogenicity testing of OmniCAR
05/07/21	PRICE SENSITIVE	364.06KB	Share
PTX Application for quotation of securities - PTX
30/06/21		24.89KB	Share
PTX PTX Completes CAR-T Manufacturing Milestone for OmniCAR
24/06/21	PRICE SENSITIVE	393.66KB	Share
PTX Response to ASX Price Query
03/06/21	PRICE SENSITIVE	404.55KB	Share
PTX Capital Structure Update - Expiry of Unlisted Options
17/05/21		300.22KB	Share
PTX PTX signs CAR-T agreement with Peter MacCallum
10/05/21	PRICE SENSITIVE	306.4KB	Share
PTX March 2021 Quarterly Update and Appendix 4C
29/04/21	PRICE SENSITIVE	215.54KB	Share
PTX PTX-200 AML Trial Progresses to Higher Dose
23/04/21	PRICE SENSITIVE	344.35KB	Share
PTX Capital Structure Update - Expiry of Unlisted Options
20/04/21		295.84KB	Share
PTX Appendix 4D and Half Year Financial Report
24/02/21	PRICE SENSITIVE	798.25KB	Share
PTX December 2020 Quarterly Update and Appendix 4C
28/01/21	PRICE SENSITIVE	314.36KB	Share
PTX PTX announces 3 next-gen CAR-T programs with OmniCAR
18/01/21	PRICE SENSITIVE	1.91MB	Share
PTX Appendix 3G
21/12/20		646.1KB	Share
PTX Change of Director's Interest Notices x4
17/12/20		478.43KB	Share
PTX Leading International Blood Cancer Specialist Joins PTX SAB
17/12/20		300.48KB	Share
PTX Appendix 3G
10/12/20		750.16KB	Share
PTX Issue of Unlisted Options
10/12/20		478.59KB	Share
PTX PTX Extends COVID-19 Testing Program with Doherty Institute
09/12/20		374.67KB	Share
PTX Amendment of Results of Annual General Meeting
25/11/20		508.67KB	Share
PTX Constitution
24/11/20		784.62KB	Share
PTX Results of Annual General Meeting
24/11/20		333.58KB	Share
PTX AGM Presentation
24/11/20	PRICE SENSITIVE	2.08MB	Share
PTX Ceasing to be a substantial holder from AEF
20/11/20		248.19KB	Share
PTX Prescient Receives $1.03m R&D Tax Rebate
11/11/20	PRICE SENSITIVE	298.41KB	Share
PTX PTX receives New Patent on Companion Diagnostic for PTX-100
26/10/20		319.15KB	Share
PTX Expiry of Unlisted Options
20/10/20		131.27KB	Share
PTX September 2020 Quarterly Update and Appendix 4C
20/10/20	PRICE SENSITIVE	183.81KB	Share
PTX Notice of Annual General Meeting/Proxy Form
15/10/20		878.45KB	Share
PTX Response to ASX Query
16/09/20	PRICE SENSITIVE	335.57KB	Share
PTX Ceasing to be a substantial holder
03/09/20		57.63KB	Share
PTX Change in Substantial Holding from AEF
02/09/20		194.62KB	Share
PTX Section 708A Cleansing Notice and Appendix 2A
31/08/20		288.46KB	Share
PTX Change of Director's Interest Notice
31/08/20		79.78KB	Share
PTX Becoming a Substantial Holder from AEF
27/08/20		219.82KB	Share
PTX Ceasing to be a substantial holder from AEF
26/08/20		250.89KB	Share
PTX Proposed issue of Securities - PTX
26/08/20		25.05KB	Share
PTX PTX Raises $7 million via Strongly Supported Placement
26/08/20	PRICE SENSITIVE	147KB	Share
PTX Appendix 4G and Corporate Governance Statement
25/08/20		434.18KB	Share
PTX Appendix 4E and 2020 Annual Report
25/08/20	PRICE SENSITIVE	1.06MB	Share
PTX Appendix 2A
24/08/20		214.69KB	Share
PTX Completion of $6.5 million Share Purchase Plan
21/08/20		131.31KB	Share
PTX Update - Proposed issue of Securities - PTX
18/08/20		204.46KB	Share
PTX Successful SPP Closed Early
18/08/20	PRICE SENSITIVE	146.86KB	Share
PTX Update - Proposed issue of Securities - PTX
14/08/20		204.33KB	Share
PTX Extension of Share Purchase Plan
14/08/20	PRICE SENSITIVE	137.09KB	Share
PTX PTX Announces Cell Therapy Collaboration with Peter Mac
14/08/20	PRICE SENSITIVE	145.5KB	Share
PTX PTX-100 progresses to next cohort in basket clinical study
12/08/20	PRICE SENSITIVE	175.99KB	Share
PTX Globally Renowned CAR-T expert joins PTX Advisory Board
07/08/20		135.81KB	Share
PTX Prescient Therapeutics Investor Briefing
04/08/20		179.24KB	Share
PTX PTX-200 AML Trial Progresses to Next Dose Level
03/08/20	PRICE SENSITIVE	133.1KB	Share
PTX Share Purchase Plan Booklet
27/07/20		441.34KB	Share
PTX Section 708A Cleansing Notice
27/07/20		81.05KB	Share
PTX Proposed issue of Securities - PTX
27/07/20		29.43KB	Share
PTX Prescient Therapeutics Launches Share Purchase Plan
27/07/20	PRICE SENSITIVE	137.29KB	Share
PTX Change in substantial Holding from AEF
24/07/20		103.34KB	Share
PTX Trading Halt
24/07/20	PRICE SENSITIVE	186.08KB	Share
PTX June 2020 Quarterly Update and Appendix 4C
22/07/20	PRICE SENSITIVE	227.48KB	Share
PTX Securities Trading Policy
21/07/20		195.17KB	Share
PTX 2 PTX Assets Chosen in Doherty Institute COVID-19 Program
21/07/20	PRICE SENSITIVE	143.57KB	Share
PTX Trading Halt
20/07/20	PRICE SENSITIVE	219.28KB	Share
PTX Trading Pause
20/07/20	PRICE SENSITIVE	115.51KB	Share
PTX Change of Auditor
10/07/20		122.12KB	Share
PTX PTX Receives Two US Patents Covering PTX-200 - Amended
17/06/20		150.23KB	Share
PTX PTX Receives Two US Patents Covering PTX-200
17/06/20		142.73KB	Share
PTX Initial Director's Interest Notice
01/06/20		88.62KB	Share
PTX Appendix 3G
01/06/20		136.71KB	Share
PTX Former Juno Executive Joins Prescient Board
01/06/20		141.3KB	Share
PTX PTX universal CAR-T platform presentation
26/05/20		2.19MB	Share

REFRESH

First 2 3 4

(20min delay)
Last 3.9¢		Change -0.003(7.14%)		Mkt cap ! $31.40M

Open	High	Low	Value	Volume
4.0¢	4.1¢	3.9¢	$75.11K	1.897M

Buyers (Bids)

No.	Vol.	Price($)
2	355874	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	75	1

View Market Depth

No.	Vol.	Price($)
2	355874	0.039
6	700788	0.038
3	80513	0.037
4	399500	0.036
4	298576	0.035

Price($)	Vol.	No.
0.040	75	1
0.041	230198	2
0.042	350000	2
0.043	247971	2
0.044	100000	1

Last trade - 15.59pm 19/06/2024 (20 minute delay)


Last 4.0¢		Change -0.003 ( 2.44 %)
Open	High	Low	Volume
4.0¢	4.1¢	4.0¢	733248
Last updated 15.59pm 19/06/2024 ?

PTX (ASX) Chart

PRESCIENT THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories